One‐year treatment outcomes of ziv‐aflibercept for treatment‐naïve macular oedema in branch retinal vein occlusion

E-ISSN： 1755-3768|96|2|e256-e257

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.96, Iss.2, 2018-03, pp. : e256-e257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment outcomes of ziv‐aflibercept for treatment‐naïve polypoidal choroidal vasculopathy

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e258-e259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy of macular oedema: meta‐analysis

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 637-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment outcome of switching from ranibizumab to aflibercept in patients with central retinal vein occlusion

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 431-434

John Wiley & Sons Inc

Access to resources Recommend Favorite

Injections in retinal vein occlusions

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 42, Iss. 7, 2014-09 ,pp. : 650-655

John Wiley & Sons Inc

Access to resources Recommend Favorite